期刊文献+

Lymphatic spreading and lymphadenectomy for esophageal carcinoma 被引量:12

Lymphatic spreading and lymphadenectomy for esophageal carcinoma
下载PDF
导出
摘要 Esophageal carcinoma(EC) is a highly lethal malignancywith a poor prognosis. One of the most important prognostic factors in EC is lymph node status. Therefore, lymphadenectomy has been recognized as a key that influences the outcome of surgical treatment for EC. However, the lymphatic drainage system of the esophagus, including an abundant lymph-capillary network in the lamina propria and muscularis mucosa, is very complex with cervical, mediastinal and celiac node spreading. The extent of lymphadenectomy for EC has always been controversial because of the very complex pattern of lymph node spreading. In this article, published literature regarding lymphatic spreading was reviewed and the current lymphadenectomy trends for EC are discussed. Esophageal carcinoma (EC) is a highly lethal malignancy with a poor prognosis. One of the most important prognostic factors in EC is lymph node status. Therefore, lymphadenectomy has been recognized as a key that influences the outcome of surgical treatment for EC. However, the lymphatic drainage system of the esophagus, including an abundant lymph-capillary network in the lamina propria and muscularis mucosa, is very complex with cervical, mediastinal and celiac node spreading. The extent of lymphadenectomy for EC has always been controversial because of the very complex pattern of lymph node spreading. In this article, published literature regarding lymphatic spreading was reviewed and the current lymphadenectomy trends for EC are discussed.
出处 《World Journal of Gastrointestinal Surgery》 SCIE CAS 2016年第1期90-94,共5页 世界胃肠外科杂志(英文版)(电子版)
关键词 LYMPHADENECTOMY LYMPHATIC SPREADING ANATOMICAL LYMPHATIC system LYMPH node metastasis Esophageal cancer Lymphadenectomy Lymphatic spreading Anatomical lymphatic system Lymph node metastasis Esophageal cancer
  • 相关文献

参考文献46

  • 1Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Globalcancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID:21296855 DOI: 10.3322/caac.20107].
  • 2van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, vanBerge Henegouwen MI, Wijnhoven BP, Richel DJ, NieuwenhuijzenGA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM,Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, RozemaT, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG,Tilanus HW, van der Gaast A. Preoperative chemoradiotherapyfor esophageal or junctional cancer. N Engl J Med 2012; 366:2074-2084 [PMID: 22646630 DOI: 10.1056/NEJMoa1112088].
  • 3Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, SimesRJ, Barbour A, Gebski V. Survival after neoadjuvant chemotherapyor chemoradiotherapy for resectable oesophageal carcinoma: anupdated meta-analysis. Lancet Oncol 2011; 12: 681-692 [PMID:21684205 DOI: 10.1016/s1470-2045(11)70142-5].
  • 4Crosby T, Evans M, Gillies RS, Maynard ND. The managementof a patient with an operable carcinoma of the oesophagus. Ann RColl Surg Engl 2009; 91: 366-370 [PMID: 19622256 DOI: 10.1308/003588409x432428].
  • 5Akutsu Y, Matsubara H. The significance of lymph node statusas a prognostic factor for esophageal cancer. Surg Today 2011; 41:1190-1195 [PMID: 21874413 DOI: 10.1007/s00595-011-4542-y].
  • 6Sobin LH, Compton CC. TNM seventh edition: what's new,what's changed: communication from the International UnionAgainst Cancer and the American Joint Committee on Cancer.Cancer 2010; 116: 5336-5339 [PMID: 20665503 DOI: 10.1002/cncr.25537].
  • 7Kato H, Watanabe H, Tachimori Y, Iizuka T. Evaluation of necklymph node dissection for thoracic esophageal carcinoma. AnnThorac Surg 1991; 51: 931-935 [PMID: 2039322].
  • 8Lerut T, Nafteux P, Moons J, Coosemans W, Decker G, De LeynP, Van Raemdonck D, Ectors N. Three-field lymphadenectomyfor carcinoma of the esophagus and gastroesophageal junction in174 R0 resections: impact on staging, disease-free survival, andoutcome: a plea for adaptation of TNM classification in upper-halfesophageal carcinoma. Ann Surg 2004; 240: 962-972; discussion972-974 [PMID: 15570202].
  • 9Altorki N, Kent M, Ferrara C, Port J. Three-field lymph nodedissection for squamous cell and adenocarcinoma of the esophagus.Ann Surg 2002; 236: 177-183 [PMID: 12170022 DOI: 10.1097/01.sla.0000021583.51164.f4].
  • 10Udagawa H, Ueno M, Shinohara H, Haruta S, Kaida S, NakagawaM, Tsurumaru M. The importance of grouping of lymph nodestations and rationale of three-field lymphoadenectomy for thoracicesophageal cancer. J Surg Oncol 2012; 106: 742-747 [PMID:22504922 DOI: 10.1002/jso.23122].

同被引文献70

引证文献12

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部